The maker of instruments used in biomedical research posted revenue of $545.1 million in the period. Bio-Rad shares have increased 12 percent ...
News
- Bio-Rad: 3Q Earnings Snapshot
- Stock Market Rebounds After October Plunge
Biotech stocks, which have been battered lately, were up sharply. Alexion Pharmaceutical, which develops drugs to treat rare diseases, surged 6.81 ...
- Pacific Biosciences surges on $1.2 billion takeover offer from DNA sequencing company Illumina ...
DNA sequencing company Illumina announced in a press release that it was acquiring Pacific Biosciences for approximately $1.2 billion. Illumina ...
- Fate Therapeutics: 3Q Earnings Snapshot
The clinical-stage biotech company that develops stem cell treatments posted revenue of $1 million in the period, which also fell short of Street ...
- Cerus: 3Q Earnings Snapshot
The biomedical products company posted revenue of $15.4 million in the period. Cerus expects full-year revenue in the range of $58 million to $60 ...